BACKGROUND: This study was carried out to determine if markers of nutritional status predict for locoregional failure following intensity-modulated radiation therapy (IMRT) with concurrent chemoradiotherapy (CCRT) for squamous cell carcinoma of the head and neck (SCCHN). METHODS: We performed a retrospective chart review of 78 patients with SCCHN who received definitive CCRT. We compared patient factors, tumor characteristics, and nutritional status indicators between patients with and without locoregional failure. RESULTS: Fifteen of 78 patients (19%) experienced locoregional failure. Median follow-up for live patients was 38 months. On univariate analysis, pretreatment percentage of ideal body weight (%IBW) (p < .01), pretreatment hemoglobin (p = .04), and treatment duration (p < .01) were significant predictors of failure. On multivariate analysis, pretreatment %IBW (p = .04) and treatment time (p < .01) remained statistically significant. CONCLUSIONS: Although treatment time is an accepted risk factor for failure, differences in outcome for patients with head and neck cancer undergoing definitive CCRT based on pretreatment %IBW should be examined further.
BACKGROUND: This study was carried out to determine if markers of nutritional status predict for locoregional failure following intensity-modulated radiation therapy (IMRT) with concurrent chemoradiotherapy (CCRT) for squamous cell carcinoma of the head and neck (SCCHN). METHODS: We performed a retrospective chart review of 78 patients with SCCHN who received definitive CCRT. We compared patient factors, tumor characteristics, and nutritional status indicators between patients with and without locoregional failure. RESULTS: Fifteen of 78 patients (19%) experienced locoregional failure. Median follow-up for live patients was 38 months. On univariate analysis, pretreatment percentage of ideal body weight (%IBW) (p < .01), pretreatment hemoglobin (p = .04), and treatment duration (p < .01) were significant predictors of failure. On multivariate analysis, pretreatment %IBW (p = .04) and treatment time (p < .01) remained statistically significant. CONCLUSIONS: Although treatment time is an accepted risk factor for failure, differences in outcome for patients with head and neck cancer undergoing definitive CCRT based on pretreatment %IBW should be examined further.
Authors: A D Santin; S Bellone; R S Parrish; C Coke; D Dunn; J Roman; J W Theus; M J Cannon; G P Parham; S Pecorelli Journal: Gynecol Obstet Invest Date: 2003-07-14 Impact factor: 2.031
Authors: Jonathan George; Trinitia Cannon; Victor Lai; Luther Richey; Adam Zanation; D Neil Hayes; Carol Shores; Denis Guttridge; Marion Couch Journal: Head Neck Date: 2007-05 Impact factor: 3.147
Authors: Vinni Juneja; Patricia Keegan; Joseph E Gootenberg; Mark D Rothmann; Yuan Li Shen; Kyung Y Lee; Karen D Weiss; Richard Pazdur Journal: Clin Cancer Res Date: 2008-06-01 Impact factor: 12.531
Authors: Mary E Platek; Susan A McCloskey; Myra Cruz; Mark S Burke; Mary E Reid; Gregory E Wilding; Nestor R Rigual; Saurin R Popat; Thom R Loree; Vishal Gupta; Graham W Warren; Maureen Sullivan; Wesley L Hicks; Anurag K Singh Journal: Head Neck Date: 2012-05-22 Impact factor: 3.147
Authors: Rafi Kabarriti; Amanda Bontempo; Maria Romano; Kevin P McGovern; Alyssa Asaro; Shankar Viswanathan; Shalom Kalnicki; Madhur K Garg Journal: Support Care Cancer Date: 2018-04-18 Impact factor: 3.603
Authors: Mary E Platek; Elizabeth Myrick; Susan A McCloskey; Vishal Gupta; Mary E Reid; Gregory E Wilding; David Cohan; Hassan Arshad; Nestor R Rigual; Wesley L Hicks; Maureen Sullivan; Graham W Warren; Anurag K Singh Journal: Support Care Cancer Date: 2013-06-07 Impact factor: 3.603
Authors: Helena Orell-Kotikangas; Pia Österlund; Kauko Saarilahti; Paula Ravasco; Ursula Schwab; Antti A Mäkitie Journal: Support Care Cancer Date: 2014-11-05 Impact factor: 3.603
Authors: Hye Ri Han; Gregory M Hermann; Sung Jun Ma; Austin J Iovoli; Kimberly E Wooten; Hassan Arshad; Vishal Gupta; Ryan P McSpadden; Moni A Kuriakose; Michael R Markiewicz; Jon M Chan; Mary E Platek; Andrew D Ray; Fangyi Gu; Wesley L Hicks; Elizabeth A Repasky; Anurag K Singh Journal: Oral Oncol Date: 2020-06-16 Impact factor: 5.337
Authors: Irene Göllnitz; Johanna Inhestern; Thomas G Wendt; Jens Buentzel; Dirk Esser; Daniel Böger; Andreas H Mueller; Jörn-Uwe Piesold; Stefan Schultze-Mosgau; Ekkehard Eigendorff; Peter Schlattmann; Orlando Guntinas-Lichius Journal: Cancer Med Date: 2016-10-11 Impact factor: 4.452
Authors: Hye Ri Han; Gregory M Hermann; Sung Jun Ma; Austin J Iovoli; Kimberly E Wooten; Hassan Arshad; Vishal Gupta; Ryan P McSpadden; Moni A Kuriakose; Michael R Markiewicz; Jon M Chan; Mary E Platek; Andrew D Ray; Fangyi Gu; Wesley L Hicks; Anurag K Singh Journal: Ann Transl Med Date: 2021-05